BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Aurora Spine Announces FDA 510(k) Clearance for the AERO™ Facet Fusion System

  March 26, 2025

   · 

  3 min read
• Press Releases

  AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025

  March 26, 2025

   · 

  5 min read
• Press Releases

  Jenscare, with innovative TTVR and approved TAVR, releases 2024 annual results

  March 26, 2025

   · 

  8 min read
• Press Releases

  Axsome Therapeutics Announces FOCUS Phase 3 Trial of Solriamfetol in Adults with Attention Deficit Hyperactivity Disorder (ADHD) Achieves Primary Endpoint

  March 26, 2025

   · 

  10 min read
• Press Releases

  ReCode Therapeutics Receives U.S. FDA Orphan Drug Designation for RCT2100 for the Treatment of Cystic Fibrosis

  March 26, 2025

   · 

  3 min read
• Press Releases

  KalVista Pharmaceuticals Announces Early Completion of Enrollment in KONFIDENT-KID Pediatric HAE Trial

  March 26, 2025

   · 

  4 min read
• Press Releases

  Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR

  March 26, 2025

   · 

  8 min read
• Press Releases

  AccurEdit Therapeutics’ LNP-based In Vivo Gene Editing Product ART001 Obtained Orphan Drug Designation from the FDA

  March 26, 2025

   · 

  1 min read
• Press Releases

  Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases

  March 26, 2025

   · 

  5 min read
• Press Releases

  Relmada Therapeutics Licenses Phase 2 Bladder Cancer Candidate, NDV-01, from Trigone Pharma, Ltd.

  March 26, 2025

   · 

  10 min read